Lung Lung
Filter by:
January 9, 2025

Windham Capital Partners Appoints Former New York Medicaid Director, Jason Helgerson, and Chief Digital Officer and Chief Information Officer of Emory University, Dr. Alistair Erskine, as Venture Partners

ArrowArrow
January 9, 2025

Windham Capital Partners Appoints Former New York Medicaid Director, Jason Helgerson, and Chief Digital Officer and Chief Information Officer of Emory University, Dr. Alistair Erskine, as Venture Partners

ArrowArrow
December 2, 2024

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

ArrowArrow
December 2, 2024

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

ArrowArrow
November 21, 2024

Making care affordable again: How TailorMed is removing financial barriers to healthcare

ArrowArrow
November 21, 2024

Making care affordable again: How TailorMed is removing financial barriers to healthcare

ArrowArrow
November 19, 2024

DELFI Diagnostics Selects Lahey Hospital & Medical Center to Administer New Lung Cancer Screening Test

ArrowArrow
November 19, 2024

DELFI Diagnostics Selects Lahey Hospital & Medical Center to Administer New Lung Cancer Screening Test

ArrowArrow
October 29, 2024

Founder-Friendly Investors 2024 Introducing the Capital Providers With a Track Record of Supporting Founders

ArrowArrow
October 29, 2024

Founder-Friendly Investors 2024 Introducing the Capital Providers With a Track Record of Supporting Founders

ArrowArrow
October 28, 2024

DELFI Diagnostics Working with Incendia Therapeutics to Employ Advanced Treatment Monitoring Test in a Phase 1 Clinical Trial

ArrowArrow
October 28, 2024

DELFI Diagnostics Working with Incendia Therapeutics to Employ Advanced Treatment Monitoring Test in a Phase 1 Clinical Trial

ArrowArrow
October 15, 2024

FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer

ArrowArrow
October 15, 2024

FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer

ArrowArrow
October 7, 2024

Allegheny Health Network explores use of promising new blood-based test to enhance lung cancer detection

ArrowArrow
October 7, 2024

Allegheny Health Network explores use of promising new blood-based test to enhance lung cancer detection

ArrowArrow
September 30, 2024

Waud Capital Partners Acquires Science Exchange to Fuel Innovation in Life Sciences Supplier Orchestration Technology

ArrowArrow
September 30, 2024

Waud Capital Partners Acquires Science Exchange to Fuel Innovation in Life Sciences Supplier Orchestration Technology

ArrowArrow
August 13, 2024

Upward Health Ranks No. 6 on the 2024 Inc. 5000

ArrowArrow
August 13, 2024

Upward Health Ranks No. 6 on the 2024 Inc. 5000

ArrowArrow
July 25, 2024

Alto Neuroscience Receives Funding Award from Wellcome Trust to Accelerate Development of ALTO-100 in Bipolar Depression Leveraging Precision Psychiatry Approach

ArrowArrow
July 25, 2024

Alto Neuroscience Receives Funding Award from Wellcome Trust to Accelerate Development of ALTO-100 in Bipolar Depression Leveraging Precision Psychiatry Approach

ArrowArrow
July 15, 2024

Neuspera Medical Raises $23 Million in Series D Financing

ArrowArrow
July 15, 2024

Neuspera Medical Raises $23 Million in Series D Financing

ArrowArrow
June 11, 2024

Indigenous Pact and DELFI Diagnostics Join Forces to Enhance Lung Cancer Screening in Tribal Communities

ArrowArrow
June 11, 2024

Indigenous Pact and DELFI Diagnostics Join Forces to Enhance Lung Cancer Screening in Tribal Communities

ArrowArrow
June 4, 2024

DELFI Diagnostics Announces Equity Investment from the Merck Global Health Innovation Fund to Accelerate DELFI's Cancer Screening AI Fragmentomics Platform

ArrowArrow
June 4, 2024

DELFI Diagnostics Announces Equity Investment from the Merck Global Health Innovation Fund to Accelerate DELFI's Cancer Screening AI Fragmentomics Platform

ArrowArrow
May 13, 2024

OSF HealthCare and DELFI Diagnostics Announce Collaboration to Improve Lung Cancer Screening Rates

ArrowArrow
May 13, 2024

OSF HealthCare and DELFI Diagnostics Announce Collaboration to Improve Lung Cancer Screening Rates

ArrowArrow
April 30, 2024

WindRose Health Investors Completes Majority Growth Investment in SubjectWell

ArrowArrow
April 30, 2024

WindRose Health Investors Completes Majority Growth Investment in SubjectWell

ArrowArrow
April 23, 2024

Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia

ArrowArrow
April 23, 2024

Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia

ArrowArrow
April 2, 2024

City of Hope and DELFI Diagnostics announce collaboration to improve lung cancer screening rates in underserved areas of Los Angeles

ArrowArrow
April 2, 2024

City of Hope and DELFI Diagnostics announce collaboration to improve lung cancer screening rates in underserved areas of Los Angeles

ArrowArrow
March 1, 2024

Generative AI in Your Desk Drawer: LLMs for Everyone

ArrowArrow
March 1, 2024

Generative AI in Your Desk Drawer: LLMs for Everyone

ArrowArrow
February 29, 2024

Generative AI in Your Desk Drawer: How to Get There

ArrowArrow
February 29, 2024

Generative AI in Your Desk Drawer: How to Get There

ArrowArrow
February 26, 2024

Generative AI in Your Desk Drawer: Back Office Applications in Health Care

ArrowArrow
February 26, 2024

Generative AI in Your Desk Drawer: Back Office Applications in Health Care

ArrowArrow
February 1, 2024

DELFI Diagnostics Announces Availability of New Fragmentome-Based Cancer Treatment Monitoring Assay

ArrowArrow
February 1, 2024

DELFI Diagnostics Announces Availability of New Fragmentome-Based Cancer Treatment Monitoring Assay

ArrowArrow
January 28, 2024

Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery

ArrowArrow
January 28, 2024

Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery

ArrowArrow
January 25, 2024

Novel Approaches Are Essential for Enabling Patient-First Outcomes in Value Based Care Models

ArrowArrow
January 25, 2024

Novel Approaches Are Essential for Enabling Patient-First Outcomes in Value Based Care Models

ArrowArrow
January 5, 2024

DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer

ArrowArrow
January 5, 2024

DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer

ArrowArrow
December 26, 2023

CVRx receives FDA approval for expanded labeling of Barostim

ArrowArrow
December 26, 2023

CVRx receives FDA approval for expanded labeling of Barostim

ArrowArrow
December 13, 2023

Vergent Bioscience Initiates Phase 2, Multi-Center VISUALIZE Study Evaluating Efficacy of Tumor-targeted Fluorescent Imaging Agent VGT-309 in Lung Cancer Surgeries

ArrowArrow
December 13, 2023

Vergent Bioscience Initiates Phase 2, Multi-Center VISUALIZE Study Evaluating Efficacy of Tumor-targeted Fluorescent Imaging Agent VGT-309 in Lung Cancer Surgeries

ArrowArrow
December 4, 2023

Alto Neuroscience Announces Positive Results from Phase 2 Study of ALTO-300 in Major Depressive Disorder

ArrowArrow
December 4, 2023

Alto Neuroscience Announces Positive Results from Phase 2 Study of ALTO-300 in Major Depressive Disorder

ArrowArrow
November 21, 2023

Alto Neuroscience Closes $45 Million in Oversubscribed Series C Financing

ArrowArrow
November 21, 2023

Alto Neuroscience Closes $45 Million in Oversubscribed Series C Financing

ArrowArrow
November 17, 2023

ChromaCode Lung Cancer Assay Shows Advantages in New Data at AMP as Company Eyes Next Applications

ArrowArrow
November 17, 2023

ChromaCode Lung Cancer Assay Shows Advantages in New Data at AMP as Company Eyes Next Applications

ArrowArrow
November 17, 2023

FORE Biotherapeutics Announces Oral Presentation at SNO 2023 Reporting Updated Phase 1/2a Results for Plixorafenib in BRAF V600 Advanced Solid Tumors, Including Novel Data for Patients with BRAF V600 Primary CNS Tumors

ArrowArrow
November 17, 2023

FORE Biotherapeutics Announces Oral Presentation at SNO 2023 Reporting Updated Phase 1/2a Results for Plixorafenib in BRAF V600 Advanced Solid Tumors, Including Novel Data for Patients with BRAF V600 Primary CNS Tumors

ArrowArrow
November 15, 2023

Neuspera Medical, Inc. Announces Milestone Completion of 100th Implant in Its SANS-UUI Phase II Clinical Trial

ArrowArrow
November 15, 2023

Neuspera Medical, Inc. Announces Milestone Completion of 100th Implant in Its SANS-UUI Phase II Clinical Trial

ArrowArrow
November 2, 2023

SubjectWell Acquires PatientCentra

ArrowArrow
November 2, 2023

SubjectWell Acquires PatientCentra

ArrowArrow
October 9, 2023

DELFI Diagnostics Launches FirstLook Lung, an Accessible, Accurate New Way to Enhance Lung Cancer Screening Through a Routine Blood Test

ArrowArrow
October 9, 2023

DELFI Diagnostics Launches FirstLook Lung, an Accessible, Accurate New Way to Enhance Lung Cancer Screening Through a Routine Blood Test

ArrowArrow
October 2, 2023

‘Build A Company To Be Bought, Not Sold,' 'Match The Asset To The Capital,' And Other Advice From VC Experts

ArrowArrow
October 2, 2023

‘Build A Company To Be Bought, Not Sold,' 'Match The Asset To The Capital,' And Other Advice From VC Experts

ArrowArrow
September 29, 2023

Experts in Motion: The State of MedTech Funding

ArrowArrow
September 29, 2023

Experts in Motion: The State of MedTech Funding

ArrowArrow
September 26, 2023

Alto Neuroscience Announces Positive Results from Phase 2 Study of ALTO-100 in Post-Traumatic Stress Disorder

ArrowArrow
September 26, 2023

Alto Neuroscience Announces Positive Results from Phase 2 Study of ALTO-100 in Post-Traumatic Stress Disorder

ArrowArrow
September 11, 2023

Phase 2 Data Demonstrate Potential of Vergent Biosciences’ Tumor-Targeted Fluorescent Imaging Agent to Improve Success of Lung Cancer Surgeries

ArrowArrow
September 11, 2023

Phase 2 Data Demonstrate Potential of Vergent Biosciences’ Tumor-Targeted Fluorescent Imaging Agent to Improve Success of Lung Cancer Surgeries

ArrowArrow
September 5, 2023

Adam Fine, Founder & Managing Partner at Windham Venture Partners, on Becker's Healthcare Podcast

ArrowArrow
September 5, 2023

Adam Fine, Founder & Managing Partner at Windham Venture Partners, on Becker's Healthcare Podcast

ArrowArrow
September 5, 2023

David Kereiakes, Managing Partner at Windham Venture Partners, on Becker's Healthcare Podcast

ArrowArrow
September 5, 2023

David Kereiakes, Managing Partner at Windham Venture Partners, on Becker's Healthcare Podcast

ArrowArrow
August 24, 2023

FORE Biotherapeutics Announces $75M in Series D Financing and CEO Transition

ArrowArrow
August 24, 2023

FORE Biotherapeutics Announces $75M in Series D Financing and CEO Transition

ArrowArrow
August 15, 2023

Upward Health Ranks No. 7 on the 2023 Inc. 5000

ArrowArrow
August 15, 2023

Upward Health Ranks No. 7 on the 2023 Inc. 5000

ArrowArrow
August 14, 2023

Why VCs are investing in value-based care

ArrowArrow
August 14, 2023

Why VCs are investing in value-based care

ArrowArrow
June 21, 2023

Windham Venture Partners Hires Successful Healthcare Investor, David Kereiakes, And Expands Presence in the Midwest

ArrowArrow
June 21, 2023

Windham Venture Partners Hires Successful Healthcare Investor, David Kereiakes, And Expands Presence in the Midwest

ArrowArrow
June 7, 2023

ChromaCode Announces Strategic Investment to Advance Development and Application of HDPCR Platform Technology for Use in Oncology Genomics

ArrowArrow
June 7, 2023

ChromaCode Announces Strategic Investment to Advance Development and Application of HDPCR Platform Technology for Use in Oncology Genomics

ArrowArrow
April 27, 2023

ChromaCode Announces Partnership with MedGenome to Bring HDPCR-based Diagnostics to India and the Middle East

ArrowArrow
April 27, 2023

ChromaCode Announces Partnership with MedGenome to Bring HDPCR-based Diagnostics to India and the Middle East

ArrowArrow
April 18, 2023

DELFI Diagnostics Presents Additional Promising Proof-of-Concept Data on its Monitoring Program at AACR 2023

ArrowArrow
April 18, 2023

DELFI Diagnostics Presents Additional Promising Proof-of-Concept Data on its Monitoring Program at AACR 2023

ArrowArrow
April 18, 2023

NEUSPERA MEDICAL ANNOUNCES FDA CLEARANCE OF ITS SYSTEM FOR PERIPHERAL NERVE STIMULATION

ArrowArrow
April 18, 2023

NEUSPERA MEDICAL ANNOUNCES FDA CLEARANCE OF ITS SYSTEM FOR PERIPHERAL NERVE STIMULATION

ArrowArrow
March 15, 2023

Clever Care announces Series C Fundraising: Adds New Board Member

ArrowArrow
March 15, 2023

Clever Care announces Series C Fundraising: Adds New Board Member

ArrowArrow
January 30, 2023

Alto Neuroscience Announces $60 Million in Additional Financing

ArrowArrow
January 30, 2023

Alto Neuroscience Announces $60 Million in Additional Financing

ArrowArrow
January 10, 2023

Alto Neuroscience Announces Positive Results for ALTO-100 in Phase 2 Study Supporting Advancement of First-in-Class Mechanism for Treating Depression

ArrowArrow
January 10, 2023

Alto Neuroscience Announces Positive Results for ALTO-100 in Phase 2 Study Supporting Advancement of First-in-Class Mechanism for Treating Depression

ArrowArrow
December 14, 2022

Alto Neuroscience Announces Positive Data from Phase 1 Study Evaluating Brain Effects of Novel Drug Combinations

ArrowArrow
December 14, 2022

Alto Neuroscience Announces Positive Data from Phase 1 Study Evaluating Brain Effects of Novel Drug Combinations

ArrowArrow
December 8, 2022

Alto Neuroscience Presents New Data Leveraging EEG and Machine Learning to Predict Individual Response to Antidepressants at the 61st Annual Meeting of the American College of Neuropsychopharmacology

ArrowArrow
December 8, 2022

Alto Neuroscience Presents New Data Leveraging EEG and Machine Learning to Predict Individual Response to Antidepressants at the 61st Annual Meeting of the American College of Neuropsychopharmacology

ArrowArrow
November 29, 2022

Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development of VGT-309 in Lung Cancer

ArrowArrow
November 29, 2022

Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development of VGT-309 in Lung Cancer

ArrowArrow
November 18, 2022

Positive Liver Cancer Detection Data Published in Cancer Discovery Shows Further Promise of Delfi's AI Liquid Biopsy Platform

ArrowArrow
November 18, 2022

Positive Liver Cancer Detection Data Published in Cancer Discovery Shows Further Promise of Delfi's AI Liquid Biopsy Platform

ArrowArrow
October 31, 2022

Valera Health Announces $45 Million Growth Equity Financing to Increase Access to Evidence-based Mental Health Services for High Acuity Patients

ArrowArrow
October 31, 2022

Valera Health Announces $45 Million Growth Equity Financing to Increase Access to Evidence-based Mental Health Services for High Acuity Patients

ArrowArrow
October 25, 2022

Alto Neuroscience Announces $35 Million Series B Financing

ArrowArrow
October 25, 2022

Alto Neuroscience Announces $35 Million Series B Financing

ArrowArrow
October 20, 2022

SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options

ArrowArrow
October 20, 2022

SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options

ArrowArrow
October 4, 2022

Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309

ArrowArrow
October 4, 2022

Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309

ArrowArrow
October 4, 2022

The Dye that Binds: Advances in Tumor Visualization Now Help Surgeons See Cancer in Real-Time

ArrowArrow
October 4, 2022

The Dye that Binds: Advances in Tumor Visualization Now Help Surgeons See Cancer in Real-Time

ArrowArrow
September 13, 2022

Upward Health Announces Growth Equity Financing Led by Heritage Group

ArrowArrow
September 13, 2022

Upward Health Announces Growth Equity Financing Led by Heritage Group

ArrowArrow
September 12, 2022

Delfi Diagnostics Selected as the Liquid Biopsy Partner for 4-IN-THE-LUNG-RUN: A Large-Scale European Lung Cancer Screening Study

ArrowArrow
September 12, 2022

Delfi Diagnostics Selected as the Liquid Biopsy Partner for 4-IN-THE-LUNG-RUN: A Large-Scale European Lung Cancer Screening Study

ArrowArrow
August 23, 2022

Upward Health Awarded ACO REACH Model Contract by CMS

ArrowArrow
August 23, 2022

Upward Health Awarded ACO REACH Model Contract by CMS

ArrowArrow
July 25, 2022

Valera Health and Horizon Healthcare Services Collaborate to Increase Access to Mental Health Care in New Jersey

ArrowArrow
July 25, 2022

Valera Health and Horizon Healthcare Services Collaborate to Increase Access to Mental Health Care in New Jersey

ArrowArrow
July 18, 2022

Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests

ArrowArrow
July 18, 2022

Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests

ArrowArrow
June 14, 2022

Neuspera Medical® Announces Second Phase of SANS-UUI IDE Clinical Trial with the Nuvella™ System

ArrowArrow
June 14, 2022

Neuspera Medical® Announces Second Phase of SANS-UUI IDE Clinical Trial with the Nuvella™ System

ArrowArrow
May 9, 2022

Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial

ArrowArrow
May 9, 2022

Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial

ArrowArrow
May 9, 2022

CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System

ArrowArrow
May 9, 2022

CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System

ArrowArrow
May 5, 2022

Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction…

ArrowArrow
May 5, 2022

Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction…

ArrowArrow
March 29, 2022

Willow® Expands Product Suite and Unveils Willow Go™, Its Fully In-Bra Wearable Breast Pump for Only $329

ArrowArrow
March 29, 2022

Willow® Expands Product Suite and Unveils Willow Go™, Its Fully In-Bra Wearable Breast Pump for Only $329

ArrowArrow
January 25, 2022

200th Treatment Milestone for AIRFLOW-3 COPD Trial

ArrowArrow
January 25, 2022

200th Treatment Milestone for AIRFLOW-3 COPD Trial

ArrowArrow
December 23, 2021

Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services

ArrowArrow
December 23, 2021

Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services

ArrowArrow
December 16, 2021

Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry

ArrowArrow
December 16, 2021

Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry

ArrowArrow
November 4, 2021

Valera Health Secures $15M Led by Windham Venture Partners to Expand the Company's Mental Health Clinical Services Across the U.S.

ArrowArrow
November 4, 2021

Valera Health Secures $15M Led by Windham Venture Partners to Expand the Company's Mental Health Clinical Services Across the U.S.

ArrowArrow
October 14, 2021

Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing

ArrowArrow
October 14, 2021

Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing

ArrowArrow
October 7, 2021

Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer

ArrowArrow
October 7, 2021

Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer

ArrowArrow
September 22, 2021

Clever Care Health Plan Raises Over $71 Million in Series B Funding to Accelerate Growth of its Medicare Advantage HMO Plan

ArrowArrow
September 22, 2021

Clever Care Health Plan Raises Over $71 Million in Series B Funding to Accelerate Growth of its Medicare Advantage HMO Plan

ArrowArrow
September 17, 2021

CVRx Added to Russell 2000® and 3000® Indexes

ArrowArrow
September 17, 2021

CVRx Added to Russell 2000® and 3000® Indexes

ArrowArrow
August 11, 2021

Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone

ArrowArrow
August 11, 2021

Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone

ArrowArrow
July 20, 2021

Neuspera Medical Announces Close of a $65M Series C Equity Financing

ArrowArrow
July 20, 2021

Neuspera Medical Announces Close of a $65M Series C Equity Financing

ArrowArrow
June 29, 2021

CVRx, Inc. Announces Upsized Pricing of Initial Public Offering

ArrowArrow
June 29, 2021

CVRx, Inc. Announces Upsized Pricing of Initial Public Offering

ArrowArrow
June 15, 2021

Personal Genome Diagnostics Enters Collaborative Partnership with Clinical Molecular Diagnostics Laboratory of Major University Health System

ArrowArrow
June 15, 2021

Personal Genome Diagnostics Enters Collaborative Partnership with Clinical Molecular Diagnostics Laboratory of Major University Health System

ArrowArrow
June 10, 2021

Upward Health Announces Contract with Clover Health to Serve Patients In Four States Under New Direct Contracting Initiative

ArrowArrow
June 10, 2021

Upward Health Announces Contract with Clover Health to Serve Patients In Four States Under New Direct Contracting Initiative

ArrowArrow
April 21, 2021

FemTech Leader Willow® Adds Diverse Set Of Investors In Extended Series C Round

ArrowArrow
April 21, 2021

FemTech Leader Willow® Adds Diverse Set Of Investors In Extended Series C Round

ArrowArrow
March 31, 2021

Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test

ArrowArrow
March 31, 2021

Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test

ArrowArrow
March 16, 2021

ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition

ArrowArrow
March 16, 2021

ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition

ArrowArrow
March 4, 2021

ControlRad® Announces FDA Clearance for ControlRad Select

ArrowArrow
March 4, 2021

ControlRad® Announces FDA Clearance for ControlRad Select

ArrowArrow
March 4, 2021

Growing Medication Management Optimization Company, Cureatr, Names New Executive Leadership

ArrowArrow
March 4, 2021

Growing Medication Management Optimization Company, Cureatr, Names New Executive Leadership

ArrowArrow
TEL: 212.235.1091
TwitterLinkedIn
Windham Capital Partners © 2022